Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,462.00
Bid: 12,462.00
Ask: 12,470.00
Change: 58.00 (0.47%)
Spread: 8.00 (0.064%)
Open: 12,500.00
High: 12,500.00
Low: 12,462.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Taiwan says China blocked deal with BioNTech for COVID-19 shots

Wed, 26th May 2021 08:36

(Adds Taiwanese official seeking U.S. and EU help)

By Yimou Lee and Ben Blanchard

TAIPEI, May 26 (Reuters) - Taiwan directly accused China for
the first time on Wednesday of blocking a deal with Germany's
BioNTech SE for COVID-19 vaccines, in an escalating
war of words after Beijing offered the shots to the island via a
Chinese company.

Taiwan has millions of shots on order, from AstraZeneca Plc
and Moderna Inc, but has received only slightly
more than 700,000 to date, and has only been able to vaccinate
about 1% of its population as COVID-19 cases surge.

While Taiwan has previously said it had been unable to sign
a final contract with BioNTech, it had only implied that Chinese
pressure was to blame.

China claims Taiwan as its territory and frequently puts
pressure on countries and firms to curtail their dealings with
the island.

President Tsai Ing-wen told a meeting of her ruling
Democratic Progressive Party that orders for the AstraZeneca and
Moderna shots had been "smoothly" booked.

"As for Germany's BioNTech, we were close to completing the
contract with the original German plant, but because of China's
intervention, up to now there's been no way to complete it," she
said.

Taiwan, which has a population of more than 23 million
people, had bought nearly 30 million shots, Tsai said, without
giving details.

BioNTech, which sells its vaccine in partnership with Pfizer
Inc, declined to comment on Tsai's remarks, but added
"we are supportive of global vaccine supply".

China has denied trying to block vaccines for Taiwan and has
offered to provide them to the island as a goodwill gesture.

APPEALS FOR U.S., EU ASSISTANCE

Lily L.W. Hsu, secretary-general of Taiwan's Foreign
Ministry, called the Chinese offer "very divisive."

At an online event hosted by the German Marshall Fund of the
United States that also involved a U.S. and an EU official, Hsu
said Taiwan was developing its own vaccine, but the earliest
that would be ready for use was July. She repeated calls Taiwan
has made for U.S and EU assistance.

"Because of the recent outbreak we desperately need vaccines
... we do need assistance in getting vaccines before our
domestic vaccine is ready for use, she said.

The top U.S. diplomat in Taipei, Brent Christensen, said on
Wednesday he was confident Taiwan could control its spike in
COVID-19 cases, noting its infection numbers remained quite low.
He said the United States and Taipei were in talks on vaccines
but did not say shots were on the way.

China's Shanghai Fosun Pharmaceutical Group Co Ltd
said on Saturday it was willing to provide Taiwan
with BioNTech COVID-19 vaccines.

Fosun signed a deal with BioNTech to exclusively develop and
commercialise the vaccine developed using BioNTech's mRNA
technology in mainland China, Hong Kong, Macau and Taiwan.

But Tsai said the island would only buy directly from the
original manufacturers, or discuss purchases with them via the
COVAX global vaccine sharing scheme.

"Only by negotiating with the original manufacturer can you
obtain the original manufacturer's direct guarantee and
responsibility for quality and safety, so as to avoid legal and
political risks," she said.

Fosun did not respond to requests for comment.

China's foreign ministry said Taiwan's channels to receive
vaccines from them were "smooth", while China's Taiwan Affairs
Office said Taipei was using excuses to stop the shots.

China was "happy to see" Fosun's willingness to provide
vaccines to Taiwan, the Chinese office added.

Several Taiwan politicians have said the need for the Fosun
shots was so urgent the government should bring them in.

But Taiwan's Health Minister Chen Shih-chung told a daily
news briefing Taiwan had seen no supporting documentation about
Fosun's version of the vaccine.

"Bring out the official documents and we can talk about it
again."
(Reporting by Ben Blanchard and Yimou Lee in Taipei and David
Brunnstrom and Michael Martina in Washington; Editing by
Christopher Cushing, Robert Birsel and Bill Berkrot)

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.